Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 4/2021

22.10.2020 | Original Article

The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study

verfasst von: Wanli Kang, Jian Du, Song Yang, Jiajia Yu, Hongyan Chen, Jianxiong Liu, Jinshan Ma, Mingwu Li, Jingmin Qin, Wei Shu, Peilan Zong, Yi Zhang, Yongkang Dong, Zhiyi Yang, Zaoxian Mei, Qunyi Deng, Pu Wang, Wenge Han, Meiying Wu, Ling Chen, Xinguo Zhao, Lei Tan, Fujian Li, Chao Zheng, Hongwei Liu, Xinjie Li, A. Ertai, Yingrong Du, Fenglin Liu, Wenyu Cui, Quanhong Wang, Xiaohong Chen, Junfeng Han, Qingyao Xie, Yanmei Feng, Wenyu Liu, Peijun Tang, Jianyong Zhang, Jian Zheng, Dawei Chen, Xiangyang Yao, Tong Ren, Yang Li, Yuanyuan Li, Lei Wu, Qiang Song, Mei Yang, Jian Zhang, Yuanyuan Liu, Shuliang Guo, Kun Yan, Xinghua Shen, Dan Lei, Yangli Zhang, Xiaofeng Yan, Liang Li, Shenjie Tang

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

In clinical practice, PTB patients have concurrent many types of comorbidities such as pneumonia, liver disorder, diabetes mellitus, hematological disorder, and malnutrition. Detecting and treating specific comorbidities and preventing their development are important for PTB patients. However, the prevalence of most comorbid conditions in patients with PTB is not well described. We conducted a large-scale, multicenter, observational study to elucidate and illustrate the prevalence rates of major comorbidities in inpatients at 21 hospitals in China. The 19 specific comorbidities were selected for analysis in this patient cohort, and stratified the inpatient cohort according to age and gender. A total of 355,929 PTB inpatients were included, with a male:female ratio of 1.98 and the proportion of ≥ 65 years PTB inpatients was the most. Approximately 70% of PTB inpatients had at least one defined type of comorbidity. The prevalence of 19 specific comorbidities in inpatients with PTB was analyzed, with pneumonia being the most common comorbidity. The prevalence of most comorbidities was higher in males with PTB except thyroid disorders, mental health disorders, etc. The prevalence of defined most comorbidities in patients with PTB tended to increase with increasing age, although some specific comorbidities tended to increase initially then decrease with increasing age. Our study describes multiple clinically important comorbidities among PTB inpatients, and their prevalence between different gender and age groups. The results will enhance the clinical aptitude of physicians who treat patients with PTB to recognize, diagnose, and treat PTB comorbidities early.
Literatur
1.
Zurück zum Zitat World Health Organization (2019) Global tuberculosis report 2019.WHO/CDS/TB /2019.15. World Health Organization, Geneva World Health Organization (2019) Global tuberculosis report 2019.WHO/CDS/TB /2019.15. World Health Organization, Geneva
6.
Zurück zum Zitat Chinese Medical Association (2005) Clinical diagnosis standard of TB for clinical technology operation (TB volumes). Beijing:People's Medical Publishing House 1–125 Chinese Medical Association (2005) Clinical diagnosis standard of TB for clinical technology operation (TB volumes). Beijing:People's Medical Publishing House 1–125
12.
Zurück zum Zitat Alavi SM, Khoshkhoy MM (2012) Pulmonary tuberculosis and diabetes mellitus: co-existence of both diseases in patients admitted in a teaching hospital in south West of Iran. Caspian J Intern Med 3(2):421–424PubMedPubMedCentral Alavi SM, Khoshkhoy MM (2012) Pulmonary tuberculosis and diabetes mellitus: co-existence of both diseases in patients admitted in a teaching hospital in south West of Iran. Caspian J Intern Med 3(2):421–424PubMedPubMedCentral
16.
Zurück zum Zitat Marjani M, Fahim F, Sadr M et al (2019) Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial. Gastroenterol Hepatol Bed Bench 12(2):138–142PubMedPubMedCentral Marjani M, Fahim F, Sadr M et al (2019) Evaluation of Silymarin for management of anti-tuberculosis drug induced liver injury: a randomized clinical trial. Gastroenterol Hepatol Bed Bench 12(2):138–142PubMedPubMedCentral
Metadaten
Titel
The prevalence and risks of major comorbidities among inpatients with pulmonary tuberculosis in China from a gender and age perspective: a large-scale multicenter observational study
verfasst von
Wanli Kang
Jian Du
Song Yang
Jiajia Yu
Hongyan Chen
Jianxiong Liu
Jinshan Ma
Mingwu Li
Jingmin Qin
Wei Shu
Peilan Zong
Yi Zhang
Yongkang Dong
Zhiyi Yang
Zaoxian Mei
Qunyi Deng
Pu Wang
Wenge Han
Meiying Wu
Ling Chen
Xinguo Zhao
Lei Tan
Fujian Li
Chao Zheng
Hongwei Liu
Xinjie Li
A. Ertai
Yingrong Du
Fenglin Liu
Wenyu Cui
Quanhong Wang
Xiaohong Chen
Junfeng Han
Qingyao Xie
Yanmei Feng
Wenyu Liu
Peijun Tang
Jianyong Zhang
Jian Zheng
Dawei Chen
Xiangyang Yao
Tong Ren
Yang Li
Yuanyuan Li
Lei Wu
Qiang Song
Mei Yang
Jian Zhang
Yuanyuan Liu
Shuliang Guo
Kun Yan
Xinghua Shen
Dan Lei
Yangli Zhang
Xiaofeng Yan
Liang Li
Shenjie Tang
Publikationsdatum
22.10.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 4/2021
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04077-2

Weitere Artikel der Ausgabe 4/2021

European Journal of Clinical Microbiology & Infectious Diseases 4/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.